Lacosamide Oral Solution
NDC 67877-732, Lacosamide Oral Solution, solution, from Ascend Laboratories, LLC.
- Product NDC
- 67877-732
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214672
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/67877-732 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-732-95 | 67877073295 | 200 mL in 1 BOTTLE (67877-732-95) |
| 67877-732-97 | 67877073297 | 465 mL in 1 BOTTLE (67877-732-97) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4ae87834-05d8-43c8-aaa3-78047d4a573cNADAC price for package 67877073295
GET /v1/drugs/nadac/67877073295
Use it
Look up 67877-732 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-732 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-732. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.